Compare Fox Corp Class A (FOXA) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class A vs Recursion Pharmaceuticals Inc — how do they compare? Fox Corp Class A trades at $56.57 (market cap $22.28B), while Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.75B). The key difference: Fox Corp Class A is far larger — about 12.7× Recursion Pharmaceuticals Inc's market cap, and Fox Corp Class A pays a 1% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| FOXA | RXRX | |
|---|---|---|
Market Cap | $22.28B | $1.75B |
Sector | Media | Health |
52-Week High | $76.11 | $6.79 |
52-Week Low | $48.79 | $2.84 |
Enterprise Value | $26.25B | $1.17B |
Dividend Yield | 1% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fox Corporation (FOXA) trades at $56.69, up 3.32% on the day, with a bearish technical signal despite recent earnings beats. The company reported strong Q1 2026 results, beating EPS estimates, and completed a transformative $22 billion acquisition of Roku in June 2026. Fundamentals show revenue growth to $16.3B in 2025 with a 13.88% net margin, while valuation metrics appear reasonable with a P/E of 14.73 and EV/EBITDA of 8.42.
The outlook balances strategic positioning through the Roku acquisition against integration risks and leverage concerns. Analyst consensus is evenly split between Buy and Hold with a $67.80 price target suggesting 19.6% upside, but technical indicators remain bearish and projected 2026 cash flow turns negative. Key risks include streaming competition, advertising cyclicality, and debt servicing from the Roku deal.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
